Drug Shortage Report for MAXIDEX

Last updated on 2019-02-05 History
Report ID 59391
Drug Identification Number 00042579
Brand name MAXIDEX
Common or Proper name MAXIDEX OINTMENT 3.5MG
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE
Strength(s) 0.1%
Dosage form(s) OINTMENT
Route of administration OPHTHALMIC
Packaging size 3.5MG
ATC code S01BA
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-09-10
Actual start date 2018-09-10
Estimated end date 2019-02-04
Actual end date 2019-02-04
Shortage status Resolved
Updated date 2019-02-05
Company comments Maxidex 0.1% Suspension 5ml is available (#742021)
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v33 2019-02-05 English Compare
v32 2019-02-04 French Compare
v31 2019-02-04 English Compare
v30 2019-02-01 French Compare
v29 2019-02-01 English Compare
v28 2019-01-30 French Compare
v27 2019-01-30 English Compare
v26 2019-01-25 French Compare
v25 2019-01-25 English Compare
v24 2019-01-09 French Compare
v23 2019-01-09 English Compare
v22 2018-11-23 French Compare
v21 2018-11-23 English Compare
v20 2018-11-16 French Compare
v19 2018-11-16 English Compare
v18 2018-11-01 French Compare
v17 2018-11-01 English Compare
v16 2018-10-23 French Compare
v15 2018-10-23 English Compare
v14 2018-10-17 French Compare

Showing 1 to 20 of 33